Epsilon M&A Deal Report - Biosynth Beteilingungs
Transaction Multiples for the Valuation of Private Companies
Private group led by KKR & Co. Inc / Biosynth Beteilingungs
No EMAT :
114416
Announced Date :
02/11/2021
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Private group led by KKR & Co. Inc
Target :
Biosynth Beteilingungs
Country :
Switzerland
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Biosynth Beteilingungs AG is a group of companies Contrat Research Organisation (CRO) manufacturing organic chemicals. > Supplies, develops and manufacturs of a wide range of biochemical and...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
|
ns |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 32
| Date | Acquirer | Target | Country | Multiples | See details |
| 24/05/2022 | Gallus (renamed Biosynth) | Aalto Bio | Ireland | ** | 114403 |
| 21/06/2021 | Charnwood Molecular | Aurelia Bioscience | England | ** | 114304 |
Source: Epsilon Research / EMAT
